Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors

Details for Australian Patent Application No. 2005315608 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Koopman, Paulus Antonius Remigius; Ziegler, Dieter; Witte, Klaus; Straub, Matthias

Agent Watermark

Pub. Number AU-B-2005315608

PCT Pub. Number WO2006/064016

Priority 60/635,963 15.12.04 US; 04106589.7 15.12.04 EP

Filing date 14 December 2005

Wipo publication date 22 June 2006

Acceptance publication date 31 March 2011

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/064016 Priority application(s): WO2006/064016

31 March 2011 Application Accepted

  Published as AU-B-2005315608

28 July 2011 Standard Patent Sealed

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005315612-Peptide fractions promoting growth and synthesis of desired product(s) into cell and/or tissue culture

2005315607-Diphenylurea derivatives useful as potassium channel activators